-
Sector Analysis
NewOman Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Oman Defense Market Report Overview The Oman defense budget is $8 billion in 2024. The country’s defense budget will grow at a CAGR of more than 2% during 2025-2029. This can be attributed to the rising arms race in the region to intercept the growing turbulence in neighboring countries such as Syria and Yemen. In addition, the increase in oil prices will facilitate increases in Oman's defense budget. Oman Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPIV-110 in Ductal Carcinoma In Situ
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPIV-110 in Ductal Carcinoma In Situ report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TPIV-110 in Ductal Carcinoma In Situ Drug Details: TPIV-110...
-
Sector Analysis
United States (US) Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
US Defense Market Report Overview The US defense budget was worth $818.8 billion in 2023, which was a 10.7% rise from the previous year. This is in response to the deteriorating global security environment such as the Russian invasion of Ukraine and continued tensions with China over territory in the South China Sea and wider Indo-Pacific. Numerous geo-strategic and domestic political imperatives continue to drive US expenditure as defense capabilities gain growing political importance. The country’s defense budget is expected to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TPIV-100 in Ductal Carcinoma In Situ
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TPIV-100 in Ductal Carcinoma In Situ report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TPIV-100 in Ductal Carcinoma In Situ Drug Details: TPIV-100...
-
Product Insights
Hip Reconstruction – NextStep Arthropedix LLC – INSITU HIP SYSTEM
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - NextStep Arthropedix LLC - INSITU HIP SYSTEM. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TPIV-100
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TPIV-100 Drug Details TPIV-100 is under development for HER2-positive breast cancer and ductal carcinoma...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TPIV-110
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TPIV-110 Drug Details TPIV-110 is under development for the treatment of Her2/neu positive breast...
-
Product Insights
Post-Operative Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Post-Operative Pain pipeline market research report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for PostOperative Pain and features dormant...
-
Sector Analysis
Global LNG Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
Global LNG Industry Outlook to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the global LNG industry. The report provides terminal name, operator name and design LNG processing capacity (liquefaction/regasification) for all active, planned, announced, suspended, and decommissioned LNG liquefaction and regasification terminals in the world by region and country for the period 2012–2022. Planned and announced (new build) LNG terminals capacity additions and existing capacity expansions by...
-
Sector Analysis
LNG Industry Outlook in Asia and Oceania to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals
LNG Industry Outlook in Asia and Oceania to 2022 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals is a comprehensive report on the Asia and Oceania LNG industry. The report provides terminal name, operator name and design LNG processing capacity (liquefaction/ regasification) for all active, planned, announced and decommissioned LNG liquefaction and regasification terminals in the region by country for the period 2012 to 2022. Planned and announced (new build) LNG terminals capacity additions...